Marine Fungal Drugs Remain Stuck at Early Development Stages, Review Finds
A new review of more than a hundred marine fungal bioactive compounds finds that only about 10 to 20 have ...
A new review of more than a hundred marine fungal bioactive compounds finds that only about 10 to 20 have ...
A new label-free affinity-capture workflow coupled to mass spectrometry recovers known receptor-binding venom toxins and prioritizes new candidates from complex ...
Researchers at HZI and HIPS activated silent bacterial genes to discover myxoglucamides, unusual natural products that bind the cancer-associated enzyme ...
A new review argues that virtual screening and AI-driven modeling have expanded the search for anti-tuberculosis drugs, but persistent mismatches ...
A Fuzzy DEMATEL analysis of twelve challenges shows that internal barriers like resistance to change and talent shortage drive downstream ...
A Phase 1 trial presented at ESMO 2026 reports a 40% objective response rate at 130 mg for ISM6331, a ...
A marine-derived compound called rutamycin B killed the amoeba Naegleria fowleri within four hours in laboratory tests and was 200 ...
Preclinical assays found that NU7441 displaced BRD4 from acetylated chromatin and impaired homologous recombination and non-homologous end joining in ovarian ...
A Stanford-developed virtual biotech used 37,000 AI agents to analyze 50,000 trials, identify markers linked to drug success and design ...
A machine-learning pipeline identified AML-selective small molecules and implicated glutathione reductase as a vulnerability that can be exploited in laboratory ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine